These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 27911336)
1. Decreased Aerobic Capacity in ANO5-Muscular Dystrophy. Ylikallio E; Auranen M; Mahjneh I; Lamminen A; Kousi M; Träskelin AL; Muurinen T; Löfberg M; Salmi T; Paetau A; Lehesjoki AE; Piirilä P; Kiuru-Enari S J Neuromuscul Dis; 2016 Nov; 3(4):475-485. PubMed ID: 27911336 [TBL] [Abstract][Full Text] [Related]
2. Clinical and genetic features of anoctaminopathy in Saudi Arabia. Bohlega S; Monies DM; Abulaban AA; Murad HN; Alhindi HN; Meyer BF Neurosciences (Riyadh); 2015 Apr; 20(2):173-7. PubMed ID: 25864073 [TBL] [Abstract][Full Text] [Related]
3. A founder mutation in Anoctamin 5 is a major cause of limb-girdle muscular dystrophy. Hicks D; Sarkozy A; Muelas N; Köehler K; Huebner A; Hudson G; Chinnery PF; Barresi R; Eagle M; Polvikoski T; Bailey G; Miller J; Radunovic A; Hughes PJ; Roberts R; Krause S; Walter MC; Laval SH; Straub V; Lochmüller H; Bushby K Brain; 2011 Jan; 134(Pt 1):171-182. PubMed ID: 21186264 [TBL] [Abstract][Full Text] [Related]
4. ANO5 mutations in the Polish limb girdle muscular dystrophy patients: Effects on the protein structure. Jarmula A; Łusakowska A; Fichna JP; Topolewska M; Macias A; Johnson K; Töpf A; Straub V; Rosiak E; Szczepaniak K; Dunin-Horkawicz S; Maruszak A; Kaminska AM; Redowicz MJ Sci Rep; 2019 Aug; 9(1):11533. PubMed ID: 31395899 [TBL] [Abstract][Full Text] [Related]
5. Clinical spectrum and gene mutations in a Chinese cohort with anoctaminopathy. Cai S; Gao M; Xi J; Liu Z; Yue D; Wu H; Bi H; Li J; Liang Z; Zhao C; Udd B; Luo S; Lu J Neuromuscul Disord; 2019 Aug; 29(8):628-633. PubMed ID: 31350120 [TBL] [Abstract][Full Text] [Related]
6. Sex differences in the involvement of skeletal and cardiac muscles in myopathic Foltz S; Wu F; Ghazal N; Kwong JQ; Hartzell HC; Choo HJ Am J Physiol Cell Physiol; 2022 Feb; 322(2):C283-C295. PubMed ID: 35020501 [TBL] [Abstract][Full Text] [Related]
7. Anoctamin-5 related muscle disease: clinical and genetic findings in a large European cohort. de Bruyn A; Montagnese F; Holm-Yildiz S; Scharff Poulsen N; Stojkovic T; Behin A; Palmio J; Jokela M; De Bleecker JL; de Visser M; van der Kooi AJ; Ten Dam L; Domínguez González C; Maggi L; Gallone A; Kostera-Pruszczyk A; Macias A; Łusakowska A; Nedkova V; Olive M; Álvarez-Velasco R; Wanschitz J; Paradas C; Mavillard F; Querin G; Fernández-Eulate G; Quinlivan R; Walter MC; Depuydt CE; Udd B; Vissing J; Schoser B; Claeys KG Brain; 2023 Sep; 146(9):3800-3815. PubMed ID: 36913258 [TBL] [Abstract][Full Text] [Related]
8. Diagnostic anoctamin-5 protein defect in patients with ANO5-mutated muscular dystrophy. Vihola A; Luque H; Savarese M; Penttilä S; Lindfors M; Leturcq F; Eymard B; Tasca G; Brais B; Conte T; Charton K; Richard I; Udd B Neuropathol Appl Neurobiol; 2018 Aug; 44(5):441-448. PubMed ID: 28489263 [TBL] [Abstract][Full Text] [Related]
9. Eight new mutations and the expanding phenotype variability in muscular dystrophy caused by ANO5. Penttilä S; Palmio J; Suominen T; Raheem O; Evilä A; Muelas Gomez N; Tasca G; Waddell LB; Clarke NF; Barboi A; Hackman P; Udd B Neurology; 2012 Mar; 78(12):897-903. PubMed ID: 22402862 [TBL] [Abstract][Full Text] [Related]
10. ANO5 gene analysis in a large cohort of patients with anoctaminopathy: confirmation of male prevalence and high occurrence of the common exon 5 gene mutation. Sarkozy A; Hicks D; Hudson J; Laval SH; Barresi R; Hilton-Jones D; Deschauer M; Harris E; Rufibach L; Hwang E; Bashir R; Walter MC; Krause S; van den Bergh P; Illa I; Pénisson-Besnier I; De Waele L; Turnbull D; Guglieri M; Schrank B; Schoser B; Seeger J; Schreiber H; Gläser D; Eagle M; Bailey G; Walters R; Longman C; Norwood F; Winer J; Muntoni F; Hanna M; Roberts M; Bindoff LA; Brierley C; Cooper RG; Cottrell DA; Davies NP; Gibson A; Gorman GS; Hammans S; Jackson AP; Khan A; Lane R; McConville J; McEntagart M; Al-Memar A; Nixon J; Panicker J; Parton M; Petty R; Price CJ; Rakowicz W; Ray P; Schapira AH; Swingler R; Turner C; Wagner KR; Maddison P; Shaw PJ; Straub V; Bushby K; Lochmüller H Hum Mutat; 2013 Aug; 34(8):1111-8. PubMed ID: 23606453 [TBL] [Abstract][Full Text] [Related]
11. Intramuscular interstitial amyloid deposition does not impact anoctaminopathy-5 phenotype. Anandan C; Milone M; Liewluck T Muscle Nerve; 2019 Jan; 59(1):133-137. PubMed ID: 30320887 [TBL] [Abstract][Full Text] [Related]
12. Phenotypic Spectrum of Myopathies with Recessive Anoctamin-5 Mutations. Vázquez J; Lefeuvre C; Escobar RE; Luna Angulo AB; Miranda Duarte A; Delia Hernandez A; Brisset M; Carlier RY; Leturcq F; Durand-Canard MC; Nicolas G; Laforet P; Malfatti E J Neuromuscul Dis; 2020; 7(4):443-451. PubMed ID: 32925086 [TBL] [Abstract][Full Text] [Related]
15. Novel ANO5 mutations causing hyper-CK-emia, limb girdle muscular weakness and Miyoshi type of muscular dystrophy. Schessl J; Kress W; Schoser B Muscle Nerve; 2012 May; 45(5):740-2. PubMed ID: 22499103 [TBL] [Abstract][Full Text] [Related]
16. A Japanese male with a novel ANO5 mutation with minimal muscle weakness and muscle pain till his late fifties. Kadoya M; Ogata K; Suzuki M; Honma Y; Momma K; Yatabe K; Tamura T; Kaida K; Miyata N; Nishino I; Nonaka I; Kawai M Neuromuscul Disord; 2017 May; 27(5):477-480. PubMed ID: 28214267 [TBL] [Abstract][Full Text] [Related]
17. Anoctamin-5 Muscular Dystrophy: Report of Two Cases with Different Phenotypes and Genotypes from the Indian Subcontinent. Mahajan S; Dhall A; Jassal B; Saluja A; Faruq M; Suri V; Rajan R; Vishnu VY; Sharma MC Neurol India; 2022; 70(5):2169-2173. PubMed ID: 36352632 [TBL] [Abstract][Full Text] [Related]